ReviewCurrent HIV/AIDS reports2022

Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?

Urvi M Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.